Panelists discuss how the PODIUM-303 study demonstrated improved progression-free survival (9.3 vs 7.4 months) and response rates (56% vs 44%) when adding retifanlimab to carboplatin-paclitaxel in ...

Case reports and case series are uncontrolled study designs known for increased risk of bias but have profoundly influenced the medical literature and continue to advance our knowledge. In this guide, ...

A recent study published in the Indian Journal of Dermatology, Venereology and Leprology uncovered a significant and ...

A high intake of red and processed meat poses a higher risk for rheumatoid arthritis than does consuming more fruits and ...